Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Shumoos H Alwaid

Shumoos H Alwaid

Islamic University College, Iraq

Title: The role of Interlukin-6 in metabolic syndrome severity within obese population

Biography

Biography: Shumoos H Alwaid

Abstract

Metabolic syndrome represents as a constellation of interconnected physiological, biochemical, clinical
and metabolic risk factors including hypertension, dyslipidemia, central obesity, glucose intolerance,
pro-inflammatory and pro-thrombotic states which reflects an underlying insulin resistance and cardio
vascular disease. Metabolic syndrome is a chronic low-grade inflammatory state starting from adipose
tissue and further recruits’ immune cells such as monocyte-macrophages. Adipose tissue has been suggested
to be a reservoir for inflammatory cells including monocytes which either migrate to or originate within
adipose tissue and release inflammatory bio mediators such as IL-6, TNFa etc. The aim of this study is to
find the correlation between inflammatory bio mediator IL-6 with the diagnostic criteria in obese metabolic
syndrome patients. A total of the (130) participants were divided into three study groups: women patients
group included 50 subjects, men patients group included 40 subjects the control group was 40 composed
of 20 healthy women and 20 healthy men. The ages of patients and control ranged 40 to 69 years old. Each
patients group was divided into subgroups according to age, BMI, WC. Lipid profile and blood sugar were
measured for all subjects. The results revealed significant increase in IL-6 level in serum of MetS patients in
compared with control group. While the result indicated there are no significant different in IL-6 between
MetS males and females. The study results also demonstrate, there is a significant positive correlation between
IL6 and TC, TG, LDL-C, BS levels in MetS patients.